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Background: Visual system homeobox gene (VSX1) plays a major role in the early development of craniofacial and
ocular tissues including cone opsin gene in the human retina. To date, few disease-causing mutations of VSX1 have
been linked to familial and sporadic keratoconus (KC) in humans. In this study, we describe the clinical features and
screening for VSX1 gene in families with KC from India.
Methods: Clinical data and genomic DNA were collected from patients with clinically diagnosed KC and their
family members. The study was conducted on 20 subjects of eight families from India. The coding exons of VSX1
gene were amplified using PCR and amplicons were analyzed by direct sequencing. Predictive effect of the
mutations was performed using Polyphen-2, SIFT and mutation assessor algorithms. Additionally, haplotypes of
VSX1 gene were constructed for affected and unaffected individuals using SNPs.
Results: In the coding region of VSX1, one novel missense heterozygous change (p.Leu268His) was identified in five KC
patients from two unrelated families. Another family of three members had a novel heterozygous change (p.Ser251Thr).
These variants co-segregated with the disease phenotype in all affected individuals but not in the unaffected
family members and 105 normal controls. In silico analysis suggested that p.Leu268His could have a deleterious
effect on the protein coded by VSX1, while p.Ser251Thr has a neutral effect on the functional properties of VSX1.
Haplotype examination revealed common SNPs around the missense change (p.Leu268His) in two unrelated KC families.
Conclusions: In this study, we add p.Leu268His, a novel missense variation in the coding region of VSX1 to the existing
repertoire of VSX1 coding variations observed in Indian patients with the characteristic phenotype of KC. The variant
p.Ser251Thr might be a benign polymorphism, but further biophysical studies are necessary to evaluate its molecular
mechanism. The shared haplotype by two families with the same variant suggests the possibility of a founder effect,
which requires further elucidation. We suggest that p.Leu268His might be involved in the pathogenesis of KC, which may
help in the genetic counselling of patients and their family.
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Keratoconus (KC: OMIM 14830) is a progressive ectatic
disorder of the cornea characterized by thinning of the
central cornea leading to protrusion and progressive, ir-
regular astigmatism. Though there are several treatment
modalities available, severe KC remains an indication for
corneal transplantation [1, 2]. The mean age of onset is
15.39 years with a prevalence of 0.0003 %–2.3 % that af-
fects both genders and all ethnicities across the globe [3].
The disease is a complex heterogeneous disorder with risk
factors like chronic eye rubbing and atopy playing a sig-
nificant role besides ultraviolet light induced oxidative
stress [4–6]. The genetic basis for keratoconus has always
been an accepted theory considering its familial occurrence
and high concordance in monozygotic twins [4, 7, 8].
Though most KC cases are sporadic, it has been noted that
6–10 % of cases have a positive family history [9, 10]. In-
heritance in KC can be dominant or recessive; with auto-
somal dominant inheritance, the disease exhibits variable
phenotypes with incomplete penetrance [9].
Linkage analysis has identified several genomic loci in KC
families thereby establishing genetic heterogeneity [11–15].
Genes with mutations (VSX1, DOCK9, TGFβI, SOD1, FLG,
ZEB1) were found to be responsible for only a small frac-
tion of KC cases in select populations around the world
[16–21]. Nevertheless,VSX1 mutations have been identified
in two different corneal phenotypes - posterior polymorph-
ous corneal dystrophy (PPCD) and KC [16]. Genetic ana-
lysis of KC patients from different ethnic backgrounds has
revealed several coding variations in the VSX1 gene
[22–26]. So far, four pathogenic VSX1 mutations have
been reported in the KC phenotype. Hence, the signifi-
cance of a genetic basis for KC is still unclear [22–26].
VSX1 is a paired-like homeodomain transcriptional fac-
tor gene localized in 20p11.21. It is expressed in the
adult cornea and adult retinal cDNA libraries [27], inner
nuclear layer of the human retina and embryonic cra-
niofacial tissue [28]. The human VSX1 gene has five
exons that encodes for a 365–amino acid protein with
homeobox DNA binding domain and a CVC (Chx10/
Vsx–1 and ceh–10) domain, which is highly con-
served among vertebrates. In this present study, we
correlate the genetic, and clinical features of KC pa-
tients and their families of Indian origin with VSX1
gene variants.
Methods
Study subjects and clinical examination
Twenty affected individuals from eight unrelated KC fam-
ilies, 11 unaffected family members, and 105 ethnically
matched normal controls were included in this study. All
patients were examined at the Cornea and Refractive
Surgery Department, Narayana Nethralaya Postgraduate
Institute of Ophthalmology, Bangalore, India. The studyfollowed the tenets of the Declaration of Helsinki and
was approved by the Institutional Ethical Committee
(IEC–C/2013/07/01). All patients underwent visual acu-
ity assessment, a detailed slit lamp examination with
topographic and pachymetric evaluation on the Penta-
cam HR (Oculus Inc.) and Orbscan (Orbtek, Baush, &
Lomb). Keratoconus was graded according to the
Amsler-Krumeich Classification [29]. If KC was de-
tected in more than one member of the family, the en-
tire family was counselled, detailed informed consent
taken, and blood collected for genetic analysis.
Genetic study
A detailed family history was taken including history of
ocular and non-ocular hereditary disorders and pedigree
charts drawn accordingly. The total genomic DNA was
isolated from peripheral blood leukocytes by the salt
precipitation method [30] from all study subjects. For
mutational analysis, the entire coding exons of VSX1
and their flanking intronic junctions were amplified by
PCR in eight probands using the primer reported else-
where [25]. The PCR products were sequenced on
3130xl Genetic Analyzer (Applied Biosystems) according
to the manufacturer’s protocol. Sequencing results were an-
alyzed in chromatogram viewer (FinchTV 1.40), pairwise
BLAST (Basic Local Alignment Search Tool) [31] to
examine if there were any changes from the normal
VSX1 sequence available in the database (NM_014588,
ENSG00000100987). The segregation of nucleotide
changes were analysed in eight affected and four un-
affected individuals from three unrelated families by
direct sequencing method. In addition, exon 4 of VSX1
was sequenced in 105 unrelated ethnically matched
normal controls to validate the pathogenicity of nucleo-
tide variations.
Bioinformatics analysis
In order to predict the effect of nucleotide change at the
protein level, we used in silico prediction servers Poly-
phen–2 (http://genetics.bwh.harvard.edu/pph2/), SIFT
(http://sift.bii.a-star.edu.sg), Mutation Assessor (http://
mutationassessor.org/v1/) and PROVEAN (http://provean.
jcvi.org/index.php). Clustal Omega (https://www.ebi.
ac.uk/Tools/msa/clustalo/) and multiple sequence align-
ment programs were used to check the evolutionary con-
servation of VSX1 protein in other vertebrates. The effect
of amino acid changes in the stability of VSX1 was
assessed by using the MUpro (version 1.0, http://mupro.
proteomics.ics.uci.edu/) prediction server (AAMSPSM).
Haplotype analysis
To examine the disease and mutation associated haplo-
types of the eight affected and four unaffected individ-
uals from two unrelated KC families, we analysed four
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and (IVS3–24C > T) flanking VSX1 by direct sequencing.
Haplotypes were constructed manually.Results
In this study, we analysed 20 affected individuals of eight
families with a clinical diagnosis of KC for mutations in
the VSX1 gene (Table 1). A novel missense coding vari-
ant (p. Leu268His) was found in five patients from two
unrelated KC families (KC_01,KC_02). Another novel
heterozygous missense change (p. Ser251Thr) was iden-
tified in a third KC family (KC_03) with two affectedTable 1 Summary of genotype and phenotype characteristics in the
Family ID Individuals Age at diagnosis/Sex Keratocon
























KC–07 I:1 53/F Yes/BE
I:2 61/M No
II:1a 34/M Yes/RE




RE: Right eye, LE: Left eye, BE: Both eye, M-Male, F-Female, The symbol (−) denotessiblings and their affected father. The clinical features of
the affected individuals are summarized in Table 2.Mutation screening of VSX1 gene
Direct sequencing analysis of patients from KC families
(KC–01_II: 2, KC–02_II:1) (Fig. 1A,B) showed a novel
heterozygous c.803 T > A (p. Leu268His) change in exon
4 (Fig. 2A) of the VSX1 gene. In these families KC was
observed in two generations suggesting an autosomal
dominant inheritance. This missense substitution had
co-segregated in five affected individuals (KC–01_II:1,I:2,
KC–02_I:2) with the disease phenotype (Fig. 1A,B).study subjects
us Segregation of VSX1 nucleotide changes
Coding variants SNPs
- rs56157240,
L268H rs12480307, rs56157240, IVS3–24C > T
L268H rs12480307, rs56157240, IVS3–24C > T
L268H rs12480307, rs56157240
- rs12480307, rs6138482, IVS3–24C > T
L268H rs12480307, rs56157240, rs6138482,
L268H rs12480307, rs56157240, rs6138482,
- rs12480307,
- rs56157240, rs6138482
S251T IVS3–24C > T
S251T IVS3–24C > T
S251T rs56157240
- rs12480307, rs56157240
- IVS3–24C > T
- rs56157240
- rs56157240, IVS3–24C > T
- rs6138482, rs56157240, IVS3–24C > T
- rs56157240,






- rs12480307, rs6138482, IVS3–24C > T
- rs12480307, rs6138482,
- rs6138482, IVS3–24C > T




the absence. Symbol (a) indicates the probands
Table 2 Clinical features of affected individuals from KC families with VSX1 coding variants












KC–01_II:2 0.15/ 0.1 + RE: Central RE, LE: Infero-superior,
asymmetry Inferior cone,
steepening corresponds with
anterior, and posterior elevation.
RE: 447 BE: + RE: + Both eyes
LE: Inferior LE : 450
KC–01_II:1 0/ 0 + RE: Central RE: Infero-superior, asymmetry,
Infero nasal cone.
RE: 482 RE: + - RE: +
LE: Normal LE: 493 LE: Normal
LE: Normal
KC–01_I:2 0.47/0 + RE: Infero
temporal cone
RE: Inferior-Superior, asymmetry,
Infero temporal cone, central
cone with skewing of axis of 40°
RE: 404 RE: + - RE: +
LE: 440 LE: Normal
LE: Normal
LE: Normal
KC–02_II:1 0.15/0.15 - RE: Central RE: Posterior elevation RE: 490 BE: + - Both eyes




KC–02_I:2 0/ 0 - RE: Normal RE: Normal RE: 506 - - RE: Normal
LE: Infero- temporal LE: Posterior elevation, LE: 488
Infero-temporal cone LE: +
KC–03_II:2 0.47/ 0.15 - RE: Central RE: Advanced KC, RE: 333 + - Both eyes




KC–03_II:1 0/0 RE: Central RE: Posterior elevation, RE: 526 - - Both eyes
LE: Inferior Central cone LE: Infero nasal cone LE: 532
KC–03_I:2 0.15/0.15 - RE: Central BE: Inferior cone, inferior- superior
asymmetry with similar involvement
in both eyes
RE: 419 - - Both eyes
LE: Central LE: 421
RE: Right eye, LE: Left eye, BE: Both eye, BCVA- Best corrected visual acuity, KC-Keratoconus, The symbols + and - represent present and absent, respectively.
M-Male, F-Female
Fig. 1 Pedigrees of the KC families with novel coding variants in VSX1 Legend: A, B, C denotes three unrelated families. Squares and circles
indicate males and females, respectively. Black symbols indicate affected members and open symbols indicate unaffected individuals. The black
arrow indicates the proband, the sign ‘+’ represents the wild type and the mutations identified are p. Leu268His, p. Ser251Thr
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Fig. 2 Novel VSX1 coding variants in KC families A, B: Comparison of DNA sequence chromatogram of an unaffected individual (top) with an
affected (bottom). A: Patients DNA from KC–01, KC–02 revealed heterozygous T-to-A (c.803 T > A) transition (black arrow) in exon 4 of VSX1,
resulting in a leucine 268 (CTC) to histidine (CAC) change (p. Leu268His). B: Affected individuals from family KC–03 shows a heterozygous T > A
(c.751 T > A) nucleotide change in exon 4 of VSX1, which altered the serine 251 (TCC) to theronine (ACC) amino acid change (p. Ser251Thr).
C: Amino acid sequence alignment of the human VSX1 protein (amino acids from 234–274) with other species. The Ser 251 and Leu 268 are
shown in red
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at position 268 was highly conserved in nine vertebrate
orthologs and other species (Fig. 2C). This nucleotide
change was not present in the 105 normal controls and
the unaffected family members.
In another two generation KC family (KC–03) (Fig. 1C),
mutation screening of VSX1 revealed a transition at exon 4
and c.751 T >A was found in three affected (II:2, II:1 I:2)
individuals (Fig. 2B). The heterozygous T >A substitution
at codon 251 (Ser251Thr) converts a highly conserved
amino acid serine (TCC) into threonine (ACC). The un-
affected mother (I:1) and 105 controls showed wild type al-
leles of VSX1. None of these identified missense variations
have so far been reported in public databases, including
NHLBI ESP (http://evs.gs.washington.edu/EVS/), dbSNP
(http://www.ncbi.nlm.nih.gov/SNP/) and 1000 Genomes
(http://www.1000genomes.org/).Clinical findings of the three unrelated KC families
Family KC–01
There are three affected and one unaffected member
(Fig. 1A). The proband (II:2) is a 20 year old male with a
refraction of–0.5 D spherical and–2.25 D cylinder in his
right eye;–1.25 D cylinder in his left eye. Corneal topog-
raphy (Pentacam, Oculus Inc) revealed grade 1 KC in
both eyes with an inferior cone with inferior-superior
asymmetry. He had a thinnest pachymetry of 447 μm
and 450 μm in his right and left eye respectively
(Fig. 3A). He underwent corneal collagen crosslinking in
both eyes and was stable at the end of the first year of
follow up. The proband’s male sibling (II:1) had a refrac-
tion of–1 D spherical with–3 D cylinder in his right eye
and–2 D spherical in the left eye. Topography mapping
determined grade 1 KC with inferior-superior asymmetry
and an inferonasal cone in the right eye with a mean
Fig. 3 Corneal topography of the KC probands with VSX1 coding variants. A. Pentacam image of patient II:2 from KC–01, both eyes show an area of
inferior steepening on the sagittal curvature map with gross inferior-superior asymmetry, more in the right eye. This area of steepening corresponds
to areas of abnormal elevation on both the anterior and posterior elevation maps with values suggestive of Keratoconus (KC) with an inferior cone.
B. In the second family (KC–02), patient II:1 has an area of central steepening on the sagittal curvature map. This area of steepening corresponds to
areas of abnormal elevation on both the anterior and posterior elevation maps with values suggestive of KC with a central cone in the left eye (OS);
right eye (OD) showing the posterior elevation, suggestive of early KC. C. The sagittal curvature on Scheimpflug imaging of patient II:2 from the third
family (KC–03) with the left eye showing (OS) an area of central steepening. The anterior and posterior curvature maps show areas of abnormal
elevation with values suggestive of KC with a central cone. The corneal thickness map also shows an area of central thinning which is corresponding
to the areas of abnormal elevation. The right eye (OD) shows a fairly central area of steepening with features suggestive of advanced KC. There is gross
posterior elevation with significant corneal thinning (thinnest pachymetry of 370 μm) in the central 3 mm zone
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482 μm. He had a normal corneal topography in the left
eye. The right eye of the patient I:2 showed grade 1 KC.
His refraction in the right eye was–4.25 D spherical
with–4.5 D cylinder and in the left eye it was–2.75 D
spherical with–3.25 D cylinder. His topography showed
a central cone with inferior-superior asymmetry and
skewing of 40° in his right eye and normal corneal top-
ography in the left eye.
Family KC–02
Consists of four individuals with two having the charac-
teristic features of KC (Fig. 1B). The patient (II:1) is a
16 year old male, with a posterior elevation on topog-
raphy mapping in the right eye with a grade 2–3 KC in
the left eye. Refraction in the right eye was –0.75 D
sphere with–1.5 D cylinder and was–8 D sphere with–5
D cylinder in the left eye; mean keratometry was 45.3 D
in the right and 53.3 D in the left eye. He had a corneal
astigmatism of 2.5 D and 3.6 D and a thinnest pachyme-
try of 490 μm and 434 μm in the right and left eye re-
spectively (Fig. 3B). The patient underwent corneal
collagen crosslinking in the left eye and was stable atfollow up two years later. The patient’s father (I:2) had
0.5 D Spherical with–1D cylinder in the right eye and
plano refraction in the left eye. His topography evalu-
ation showed normal corneal topography in the right
eye while the left eye showed corneal thinning inferiorly,
which corresponded with the posterior elevation. Grade
1 KC was noted with a mean keratometry of 43.3 D and
pachymetry of 488 μm in the left eye.
Family KC–03
This family had one unaffected parent and three individ-
uals with the clinical features of KC (Fig. 1C). The pro-
band (II:2) is an 18 yr old male. Refraction in his right eye
was–10 D sphere with–2.25 D cylinder and–3.75 D cylin-
der in the left eye. The right eye showed advanced KC
with a fairly central cone while the left eye showed a grade
2 KC with a mean keratometry of 50.2 D and a thinnest
pachymetry of 443 μm (Fig. 3C). He underwent corneal
collagen crosslinking in both eyes and was stable on follow
up. His sister (II:1) at initial presentation had a normal
topography. At the second year follow up (20 years of
age), the left eye showed progression to grade 1 keratoco-
nus while the right eye remained stable. Both eyes of the
Table 3 The functional classification and score of VSX1 variants are predicted by using various bioinformatics tools
c. DNA position Protein change Location of protein Polyphen–2 humDiv SIFT Mutation assessor PROVEAN
c.751 T > A p. Ser251Thr CVC domain Benign (0.9) Tolerated Neutral Neutral
(0.17) (0.485) –2.467
c.803 T > A p. Leu268His CVC domain Possibly damaging for function (1.0) Deleterious Functional effect on protein Deleterious
(0.05) –6.831(1.905)
Prediction servers are Polymorphism Phenotyping v2 (PolyPhen–2), Sorting Tolerant From Intolerant (SIFT), Protein Variation Effect Analyzer (PROVEAN),
CVC (Chx10/Vsx–1, and ceh–10)
Polyphen–2 scores: 0: benign, 1 possibly damaging for function; 2: Probably damaging for function
SIFT scores: Intolerant or deleterious: score ≤0.05, Tolerant: score >0.05
Mutation Assessor scores: 0–1: no functional effect, 2–3: functional effect on protein function
Provean scores: Cut off threshold = −2.5,
-Variants with a score equal to or below −2.5 are considered “deleterious,”-Variants with a score above −2.5 are considered “neutral
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eye was–6 D spherical with a cylinder of–3.5 D and in the
left eye, a sphere of–7.5 D with cylinder of–5 D. His top-
ography scans in both eyes showed inferior steepening
with a significant inferior-superior asymmetry.
In silico analysis of the VSX1 missense variants
In silico prediction algorithms of SIFT, Polyphen–2,
Provean, and Mutation assessor suggested that the mis-
sense change p. Leu268His might negatively affect the
function of the coding protein. On the other hand, p.
Ser251Thr showed a neutral effect on the functional
properties of the protein according to the prediction
server results (Table 3). Analysis of amino acid mutation
stability for p. Leu268His using the Amino Acid Muta-
tion Stability Prediction Server showed a decrease in
the stability of VSX1 protein structure.
Haplotype analysis
We carried out haplotype analysis to examine whether the
missense change, p. Leu268His, was due to a founder effect
or was likely to have arisen independently in two unrelated
families with KC. The haplotype of affected and unaffected
individuals were constructed and compared between fam-
ilies using polymorphic SNPs (rs12480307, rs6138482,
rs56157240), and (IVS3–24C >T) markers flanking the
VSX1 gene (Table 4). The haplotype analysis showed that
three SNP markers (rs12480307, rs6138482, rs56157240)Table 4 Details of SNP markers used for the haplotype analysis
db SNP ID Physical position VSX1 transcript ID cDNA change
rs12480307 chr20: 25078910 NM_014588 c.546A > G
rs56157240 chr20: 25078745 NM_014588 c.627 + 84 T >
rs6138482 chr20: 25078806 NM_014588 c.627 + 23G >
(IVS3-24C) chr20: 25078976 NM_014588 c.504-24C > T
aAllele and population frequencies were determined by 1000 Genomes Project Phawere shared by five affected individuals (KC–01, KC–02),
both families from an endogamous community. (Fig. 4A, B).
The affected, and unaffected individuals from the third
family (KC–03) showed a different haplotype (Fig. 4C).
Discussion
Various mutation detection studies have reported that
VSX1 coding variants are associated with KC and PPCD
in different ethnic groups (Table 5) [16, 22, 24–26]. In this
study, we screened 20 patients of eight unrelated families
with KC for mutations in the VSX1 gene. Among these,
five patients from two families had a novel coding variant
(p. Leu268His) while another variant (p. Ser251Thr) was
identified in a KC family with three affected individuals.
The VSX1 consists of a paired-like homeodomain (HD)
with a highly conserved CVC domain in the C-terminal,
essential for the proliferation, and survival of retinal pro-
genitor cells and bipolar interneurons [32]. The probands
from the KC families (KC–01_II: 2, KC–02_II:1) had a
heterozygous c.803 T > A nucleotide change associated
with clinical features of bilateral KC with a typical sign
of Fleisher’s ring. The leucine 268 amino acid residue
was located in the C-terminal region of the CVC do-
main of VSX1 protein. So far only two mutations have
been reported in this region in familial KC patients and
PPCD [16, 24]. This amino acid change (p. Leu268His)
in the CVC domain implied drastic modifications in the
physicochemical properties, since leucine is a neutralProtein change Allele frequencya Population frequencya
p.A182A A : 0.748 A : 75 %
G : 0.252 G : 25 %
A - T: 0.252 T: 25 %
A: 0.748 A: 75 %
A - G: 0.735 G: 74 %
A: 0.265 A: 26 %
- C:0.999 Not available
T:0.001
se 1, HapMap, and ESP for human
Fig. 4 Pedigrees and haplotype analysis of VSX1 containing L268H and S251T variants in KC families. Legend: A,B,C The haplotype segregating
with L268H and S251T are presented on white and gray backgrounds, respectively. Sharing of three common SNPs markers (KC–01,KC–02)
families were shown in red
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residue. It may cause abnormal protein folding that may
affect DNA binding properties of the VSX1 transcrip-
tional modulation activity. Moreover, this coding variant
(p. Leu268His) leads to the replacement of highly con-
served amino acid leucine by histidine in the VSX1 protein,
perhaps implicating the functional consequence of this re-
gion. Interestingly, CVC domain change (p. His244Arg)
has been associated with PPCD along with signs of bipolar
cell dysfunction and macular degeneration [33]. AccordingTable 5 Summary of VSX1 coding variants identified in patients with
Coding variants Clinical significance Phenotype Unrelate
Controls
p. Leu17Pro Pathogenicb KC -
p. Leu17Val Non-pathogenic KC +
p. Pro58Leu Pathogenicbc KC -
p. Asp144Glu Unknown PPCD -
p. Leu159Met Unknown KC -
p. Asn151Ser Pathogenicb KC -
p. Gly160Asp Non-pathogenic PPCD -
p. Gly160Val Non-Pathogenic KC +
p. Val199Leu Non pathogenic KC +
p. Arg166Trp Unknown KC +
p. Gln175His Unknown KC -
p. Arg217His Non- Pathogenic KC +
p. Gly239Arg Pathogenicbc KC -
p. His244Arg Unknown KC +
p. Ser251Thra Unknown KC -
p. Pro247Arg Non-pathogenic KC +
p. Leu268Hisa Pathogenicbc KC -
Coding variants of the VSX1 gene have been reported in presenta and other studies
KC: Keratoconus, PPCD: Posterior polymorphous corneal dystrophy, The symbols “ +to SIFT, Polyphen-2, Provean, and Mutation assessor, the
(p. Leu268His) mutation is found to have a deleterious ef-
fect on protein function, attributing a pathogenic nature to
this missense mutation in VSX1. Furthermore, in our
study, this potentially damaging mutation was detected in
two families consisting of five affected individuals with a
dominant inheritance of KC. This is consistent with previ-
ous findings that missense mutations (p. Arg166Trp,
p. His244Arg) in VSX1 were identified in patients with
dominant inheritance of KC phenotype [24]. AnotherKC and PPCD




Italian, Ashkenazi Jewish, British, European [16, 26, 34–37]
Caucasian [16, 38]
Korean [39]
Italian, European [16, 26, 40]
Korean [23, 39]
Korean [23]
Caucasian, Iranian [16, 24]
Indian [25]
Indian, Pakistan, European [40, 41]
Italian [42]
Caucasian, Iranian [16, 24, 38, 43]
Indian Present study
Italian [16, 26, 35]
Indian Present study
based on original reportb and bioinformatics predictionsc
” and “-” represent present and absent, respectively
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Gln175His in the homeodomain of VSX1 in an Indian
family of KC with incomplete penetrance [25].
The probands from KC families showing the variable
clinical phenotype, which has been observed in earlier
studies as well [34]. On the other hand, it is difficult to es-
tablishing a genotype–phenotype correlation in the study
subjects due to the presence of inter and even intra-
familial clinical variability. Another novel c.751 T >A mis-
sense variant was identified in a proband (KC–03_II:2)
who exhibited bilateral KC. It is interesting to note that
this (p. Ser251Thr) coding variant introduces a missense
change that leads to the replacement of highly conserved
serine by threonine in the CVC domain of VSX1, probably
highlighting the functional importance of this region of
the protein. Though serine and threonine have similar
properties, threonine is less polar than serine due to the
presence of an extra non-polar methyl group. In this con-
text, it may affect the interaction with neighbouring resi-
dues that may lead to improper polypeptide folding, thus
affecting the protein’s wild-type function. Although this
variant was absent in 105 normal controls, in silico studies
suggest that p. Ser251Thr might be a benign or neutral
variant that may not affect the protein function. At this
stage, it is difficult to conclude about the pathogenic na-
ture of variants p. Leu268His and p. Ser251Thr. While
some previous studies have concluded that missense
substitutions in the VSX1 may or may not be a disease-
causing variant [16, 35], others have reported that the
mutations were actually non-pathogenic or showed poly-
morphism [35]. Recent studies have shown that the ab-
sence of VSX1 mutations in a large number of unrelated
KC patients suggesting a multiple gene involvement with
environmental interaction playing a significant role in the
pathogenesis of the disease [36, 37]. Haplotype analysis
demonstrated a sharing of common SNPs around the mis-
sense change (p. Leu268His) in two unrelated KC families,
suggesting the possibility of a founder effect, which re-
quires further investigation. The disease causative variants
identified in this study were compared to the reported lit-
erature of 1–3 % is high (2 probands out of 8, 25 %), prob-
ably due to the families belonging to an endogamous
community and coincidental selection of study population
with high VSX1 mutations. Further screening of the cod-
ing variant (p. Ser251Thr) on a large cohort of familial KC
cases may reveal the exact pathological role of the VSX1
gene. In the eight families who were analysed for VSX1
mutation screening, we were able to identify a novel mis-
sense change (p. Leu268His) in two families and a variant
of unknown significance (p. Ser251Thr) in a third family.
Screening for other candidate genes including SOD1,
ZEB1, TGFB1, FLG in KC families could determine the
underlying genetic mechanism of the disease in VSX1 mu-
tation negative patients.Conclusions
In summary, we add one novel missense variation in the
coding region of VSX1 to the existing repertoire of
VSX1 coding variants observed in Indian patients with
the characteristic phenotype of KC. Another variant p.
Ser251Thr that was identified may be a benign poly-
morphism or a variant of unknown significance. Further
biophysical studies are necessary to evaluate the precise
molecular mechanism of VSX1 caused by this variant.
The variation p. Leu268His may be involved in the
pathogenesis of KC and therefore help in the genetic
counselling of patients and their family.
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